STOCK TITAN

IsoPlexis to Report Third Quarter Financial Results on November 10, 2021

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

IsoPlexis Corporation (Nasdaq: ISO) announced it will report its third-quarter financial results on November 10, 2021, before market open. A conference call will follow at 5:30 a.m. PT / 8:30 a.m. ET, which will be webcast on the company's website. IsoPlexis focuses on single-cell proteomics to aid in developing personalized therapeutics. Its technology is utilized by top pharmaceutical companies and cancer centers for complex diseases.

Positive
  • Upcoming financial report may provide insights into company growth.
  • Partnerships with top 15 pharmaceutical companies and major cancer centers indicate strong market presence.
Negative
  • None.

BRANFORD, Conn., Oct. 26, 2021 /PRNewswire/ -- IsoPlexis Corporation (Nasdaq: ISO), a leader in functional single-cell proteomics, today announced it will report financial results for the third quarter 2021 before market open on Wednesday, November 10, 2021. Company management will be webcasting a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time.

Live audio of the webcast will be available on the "Investors" section of the company website at: www.isoplexis.com. The webcast will be archived and available for replay after the event.

About IsoPlexis

IsoPlexis is a life science technology company building solutions to accelerate the development of curative medicines and personalized therapeutics. Our award-winning single-cell proteomics systems reveal unique biological activity in small subsets of cells, allowing researchers to connect more directly to in vivo biology and develop more precise and personalized therapies. Our integrated systems, named top innovation or design by the Scientist Magazine, Fierce, BIG Innovation, Red Dot & multiple others, are used globally to advance the field of single-cell biology into new 'omic possibilities, as our customers generate solutions to overcome the challenges of complex diseases and therapeutics. Our products have been adopted by researchers around the world, including the top 15 global pharmaceutical companies by revenue and by nearly half of comprehensive cancer centers in the U.S.

Investor Contact
investors@isoplexis.com

Press Contact
press@isoplexis.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/isoplexis-to-report-third-quarter-financial-results-on-november-10-2021-301408360.html

SOURCE IsoPlexis

FAQ

When will IsoPlexis release its Q3 2021 financial results?

IsoPlexis will release its Q3 2021 financial results before the market opens on November 10, 2021.

What time is the IsoPlexis conference call for Q3 2021 results?

The IsoPlexis conference call for Q3 2021 results will begin at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time.

Where can I listen to the IsoPlexis Q3 2021 results webcast?

The Q3 2021 results webcast can be listened to on the 'Investors' section of the IsoPlexis website.

What does IsoPlexis focus on in the life sciences?

IsoPlexis focuses on functional single-cell proteomics to accelerate the development of curative medicines and personalized therapeutics.

ISO

NASDAQ:ISO

ISO Rankings

ISO Latest News

ISO Stock Data

30.28M
32.15M
15.52%
76.92%
0.29%
Medical Devices
Healthcare
Link
United States
Branford